
Sign up to save your podcasts
Or


A general partner the firm, she describes her career path, including time spent at Goldman Sachs and Genentech, before landing at Canaan over a decade ago. She discusses the firm's investment approach to healthcare, and boldly moving into new categories of medicine even in cases where an organization doesn't have existing commercial infrastructure.
By BiotechTV5
55 ratings
A general partner the firm, she describes her career path, including time spent at Goldman Sachs and Genentech, before landing at Canaan over a decade ago. She discusses the firm's investment approach to healthcare, and boldly moving into new categories of medicine even in cases where an organization doesn't have existing commercial infrastructure.

43,713 Listeners

124 Listeners

9,157 Listeners

325 Listeners

7,179 Listeners

61 Listeners

5,552 Listeners

9,948 Listeners

86 Listeners

33 Listeners

1,313 Listeners

19 Listeners

510 Listeners

12 Listeners

0 Listeners

4 Listeners

2 Listeners

7 Listeners